GlobeNewswire
AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0
📈
AI Sentiment
Highly Positive
10/10
Pfizer Inc. News
Latest updates and market news for PFE
20 news
Feb 26 - Mar 4, 2026
Page 1
Simply Wall St.
Pfizer Oncology Milestones Reshape Outlook Beyond COVID 19 Revenues
📈
AI Sentiment
Highly Positive
8/10
Zacks
BMY Gains 11.4% in a Month: Should You Buy, Sell or Hold the Stock?
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Valneva to Participate in Upcoming Investor Conferences
📈
AI Sentiment
Highly Positive
8/10
Zacks
Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026?
➖
AI Sentiment
Neutral
4/10
The Fly
Netflix upgraded, Pinterest downgraded: Wall Street's top analyst calls
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
📈
AI Sentiment
Highly Positive
9/10
Motley Fool
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
📉
AI Sentiment
Negative
2/10
Motley Fool
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
➖
AI Sentiment
Neutral
4/10
Insider Monkey
Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM
➖
AI Sentiment
Neutral
4/10
Simply Wall St.
Assessing Novavax (NVAX) Valuation After Surprise Q4 Profitability And New Pfizer Licensing Deal
📊
AI Sentiment
Positive
7/10
MT Newswires
Merck Says Keytruda Plus Padcev Decreases Risk of Death in Bladder Cancer Trial
📊
AI Sentiment
Positive
6/10
Zacks
The Zacks Analyst Blog Highlights Meta Platforms, Netflix, Pfizer, SIFCO Industries and Altigen Communications
➖
AI Sentiment
Neutral
5/10
Business Wire
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
📈
AI Sentiment
Highly Positive
10/10
Simply Wall St.
Pfizer’s New BRAFTOVI Approval Broadens Oncology Reach And Investor Debate
📈
AI Sentiment
Highly Positive
8/10
Share this news page